BOCA RATON, Fla., Sept. 20, 2017 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will present at the Ladenburg Thalmann Healthcare Conference on Tuesday, September 26, 2017 at 4:00 p.m. Eastern time. The conference is being held that day at the Sofitel Hotel in New York City.
As previously announced, management will be presenting at the Sidoti & Company Fall 2017 Conference on Thursday, September 28 at 11:25 a.m. This presentation will be webcast live and available for replay in the Investor Relations section of the Company's website at sensushealthcare.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit https://sensushealthcare.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
[email protected]
View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-present-at-the-ladenburg-thalmann-2017-healthcare-conference-300522434.html
SOURCE Sensus Healthcare
